5% polymer gel with CBD application
Bilateral application of 5% polymer gel with CBD intraorally, on the masseter muscle
Loading study record…
Loading study record…
The aim of the project is to assess the effectiveness of reducing the masseter muscles tension and hyperactivity in patients with a painful form of TMD by using polymers containing CBD compared to placebo polymers.
Locally preserved from ClinicalTrials.govOpen ClinicalTrials.govlast source update 2023-07-21
What this record can show
This locally preserved record separates the registered protocol from source-reported registry results. Neither is a treatment recommendation.
Registry facts
Since the healing properties of CBD have been known for a long time, the assumption of the proposed research is to reduce the tension of the masseter muscles, reduce the bruxism index and occlusal strength, as well as reduce pain, from which patients with TMD suffer. CBD intraoral application therapy seems promising in that field. Patients attending The Department of TMD in Zabrze, Polska will be randomly divided into two groups: experimental and placebo. sEMG activity values will be compared during 14 and 30 days therapy with polymers. the efficacy of the cannabis cream used in the study. Positive results will confirm the efficacy of CBD relaxing properties used in the study, compared to placebo.
Linked local records
Local links use governed condition terms or exact source-reported intervention names. They are navigation candidates, not efficacy claims.
Research network
Interventions
Bilateral application of 5% polymer gel with CBD intraorally, on the masseter muscle
Bilateral application of 10% polymer gel with CBD intraorally, on the masseter muscle
Application of placebo without CBD
Eligibility
primary outcomes
Time frame: 30 days
Change in masseter muscle electromyographic activity-sEMG examination
Time frame: 30 days
Changes of felt pain recorded by means of VAS scale
Publications